(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010HEALTHCARE IN FOCUS: Liz Krutoholow, Specialty Pharma and Biotech Analyst for Bloomberg Intelligence, on Mylan selling a generic version of EpiPen to quell outcry over pricing.

Apple Slides Most Since 2025 After Supply Shortages Hurt Outlook
17:44

Instant Reaction: Apple Slides After Supply Shortages Hurt Its Sales Forecast
10:27

Instant Reaction: Amazon Reports Cloud Sales Growth for Fifth Straight Quarter
18:09